User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

Primary tabs

download
  • Open access
  • PDF
  • 191.59 K
Franchimont, Denis Ferrante, Marc Louis, Edouard De Vos, Martine Dewit, Olivier [UCL] Moreels, Tom [UCL] Rahier, Jean-François [UCL] Vermeire, Séverine

(eng) Biosimilars are biological drugs which are similar to the authorized biologics (“reference product”) but not identical (1). The European legislation has offered since 2006 a legal framework for biosimilars. The concept and methodology of the comparative investigations are further treated in the guidelines of the European Medicines Agency (EMA) [...]

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2018
Language Anglais
Journal information "Acta gastro-enterologica Belgica" - Vol. 81, no. 1, p. 49-53 (2018)
Peer reviewed yes
Publisher Universa Press ((Belgium) Wetteren)
issn 1784-3227
Publication status Publié
Affiliations UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - SSS/IREC/SLUC - Pôle St.-Luc
UCL - SSS/IREC/MONT - Pôle Mont Godinne
UCL - (MGD) Service de gastro-entérologie
UCL - (SLuc) Service d'hépato-gastro-entérologie
Keywords Crohn's disease ; Anti-TNF ; Biosimilar ; Inflammatory bowel disease ; Ulcerative colitis
Links
Bibliographic reference Franchimont, Denis ; Ferrante, Marc ; Louis, Edouard ; De Vos, Martine ; Dewit, Olivier ; et. al. Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).. In: Acta gastro-enterologica Belgica, Vol. 81, no. 1, p. 49-53 (2018)
Permanent URL http://hdl.handle.net/2078.1/201904